opusgtx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://opusgtx.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Home - Opus |
| Description | Groundbreaking gene therapy built by and for patients with rare inherited retinal diseases |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 173.201.177.53 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
opusgtx.com Valuation
|
US$5,144,882
Last updated: 2023-05-11 15:36:21
opusgtx.com has Semrush global rank of 2,057,249. opusgtx.com has an estimated worth of US$ 5,144,882, based on its estimated Ads revenue. opusgtx.com receives approximately 593,641 unique visitors each day. Its web server is located in United States, with IP address 173.201.177.53. According to SiteAdvisor, opusgtx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,144,882 |
| Daily Ads Revenue | US$4,750 |
| Monthly Ads Revenue | US$142,474 |
| Yearly Ads Revenue | US$1,709,684 |
| Daily Unique Visitors | 39,577 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| opusgtx.com. | A | 7199 | IP: 173.201.177.53 |
| opusgtx.com. | NS | 3600 | NS Record: ns76.domaincontrol.com. |
| opusgtx.com. | NS | 3600 | NS Record: ns75.domaincontrol.com. |
| opusgtx.com. | MX | 3600 | MX Record: 0 OpusGtx-com.mail.protection.outlook.com. |
| opusgtx.com. | TXT | 1800 | TXT Record: mt-29547268 |
| opusgtx.com. | TXT | 1800 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-11 15:36:21
| About Us Company Overview Management Board of Directors Scientific & Clinical Advisors Patients & Families Our Approach Overview Scientific Publications Pipeline & Programs News & Events Press Releases In the News Events Contact Opus Genetics Envisioning a new future for patients with inherited retinal diseases Groundbreaking gene therapy Groundbreaking gene therapy built by and for patients with rare inherited retinal diseases (IRD) Backed by Foundation Fighting Blindness’s venture arm, the Retinal Degeneration Fund, Opus Genetics combines unparalleled insight and commitment toward patient need with wholly owned programs in numerous rare retinal diseases to create important new AAV-based retinal gene therapies for patients. Patient-Guided Gene Therapy Pipeline Unique Approach Preserving vision Targeting mutations in genes causing inherited retinal diseases Opus Genetics’ focus is on developing and advancing treatments to address mutations in genes that cause loss of vision, including |
HTTP Headers
HTTP/1.1 200 OK Date: Fri, 05 Nov 2021 01:09:27 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Mon, 18 Oct 2021 14:14:32 GMT ETag: "1420fcf-2cb2-5cea129fba260" Accept-Ranges: bytes Content-Length: 11442 Vary: Accept-Encoding Content-Type: text/html |
opusgtx.com Whois Information
Domain Name: OPUSGTX.COM Registry Domain ID: 2583345440_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-01-07T21:07:28Z Creation Date: 2021-01-07T21:07:27Z Registry Expiry Date: 2023-01-07T21:07:27Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS75.DOMAINCONTROL.COM Name Server: NS76.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-04T07:15:26Z <<< |